{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:36:14Z","timestamp":1792794974372,"version":"4.5.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psoriasis is a chronic immune-mediated inflammatory skin disease characterized by epidermal dysfunction, aberrant keratinocyte activation, and complex immune remodeling. Although lipid dysregulation has increasingly been implicated in psoriasis, the role of palmitoylation-associated genes in cutaneous inflammation remains insufficiently defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We integrated bulk transcriptomic datasets (GSE14905, GSE13355, and GSE121212) and a single-cell RNA-sequencing dataset (GSE151177) to identify palmitoylation-associated biomarkers in psoriasis. Weighted gene co-expression network analysis, differential expression analysis, and machine-learning algorithms including LASSO and SVM-RFE were applied to screen hub genes. Functional enrichment, immune microenvironment analysis, regulatory-network construction, and candidate-drug prediction were subsequently performed. In addition, RT-qPCR was used to validate the expression of candidate genes in psoriatic lesional skin and healthy control skin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified 209 palmitoylation-associated differentially expressed genes and screened five candidate hub genes:\n                      <jats:italic>CERK<\/jats:italic>\n                      ,\n                      <jats:italic>SPTSSA<\/jats:italic>\n                      ,\n                      <jats:italic>TNFSF10<\/jats:italic>\n                      ,\n                      <jats:italic>CTNS<\/jats:italic>\n                      , and\n                      <jats:italic>HSD17B10<\/jats:italic>\n                      . External validation supported the relative robustness of\n                      <jats:italic>SPTSSA<\/jats:italic>\n                      ,\n                      <jats:italic>TNFSF10<\/jats:italic>\n                      , CTNS, and\n                      <jats:italic>HSD17B10<\/jats:italic>\n                      , whereas\n                      <jats:italic>CERK<\/jats:italic>\n                      remained a biologically relevant mechanistic candidate. A four-gene score derived from\n                      <jats:italic>SPTSSA<\/jats:italic>\n                      ,\n                      <jats:italic>TNFSF10<\/jats:italic>\n                      , CTNS, and\n                      <jats:italic>HSD17B10<\/jats:italic>\n                      defined a high-score state enriched in inflammatory, proliferative, and metabolic-stress pathways, including interferon responses, IL-6\u2013JAK\u2013STAT3 signaling, TNF signaling via NF-\u03baB, complement, and inflammatory response. Immune deconvolution further revealed increased macrophage and activated dendritic-cell infiltration together with coordinated upregulation of multiple immune checkpoint molecules. Single-cell and correlation analyses suggested that\n                      <jats:italic>SPTSSA<\/jats:italic>\n                      showed relatively stronger expression in basal cells and keratinocytes, supporting a closer association with epidermal programs.\n                      <jats:italic>CTNS<\/jats:italic>\n                      also exhibited a mainly epidermal distribution, particularly in keratinocytes, whereas\n                      <jats:italic>TNFSF10<\/jats:italic>\n                      displayed a more immune-related pattern and\n                      <jats:italic>HSD17B10<\/jats:italic>\n                      showed a broader immune-metabolic distribution across multiple cell populations. RT-qPCR further supported the lesional upregulation of\n                      <jats:italic>SPTSSA<\/jats:italic>\n                      and\n                      <jats:italic>HSD17B10<\/jats:italic>\n                      , while\n                      <jats:italic>CERK<\/jats:italic>\n                      showed an opposite tissue-level trend and was therefore retained as a mechanistically informative candidate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identifies a palmitoylation-associated molecular signature related with sphingolipid metabolism, keratinocyte activation, and immune remodeling in psoriasis. These findings not only provide candidate biomarkers for disease stratification, but also highlight potentially druggable pathways and therapeutic targets for future translational investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1856647","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:20:13Z","timestamp":1784607613000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated transcriptomic and tissue-validation analyses identify palmitoylation-associated biomarkers linked to sphingolipid metabolism and immune remodeling in psoriasis"],"prefix":"10.3389","volume":"17","author":[{"given":"Qingqiong","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongcan","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]},{"name":"Institute of Psoriasis, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]},{"name":"Institute of Psoriasis, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenyong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Shanghai Tenth People\u2019s Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis-current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15913","article-title":"Pathophysiology of psoriasis: a review","volume":"48","author":"Yamanaka","year":"2021","journal-title":"J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01549","article-title":"The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03726-1","article-title":"Immune responses and therapeutic options in psoriasis","volume":"78","author":"Afonina","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110242","article-title":"Single-cell technologies in psoriasis","volume":"264","author":"Cui","year":"2024","journal-title":"Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e20202345","DOI":"10.1084\/jem.20202345","article-title":"Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis","volume":"218","author":"Nakamizo","year":"2021","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2024.101306","article-title":"Unveiling multifaceted roles of myeloid innate immune cells in the pathogenesis of psoriasis","volume":"99","author":"Park","year":"2024","journal-title":"Mol Aspects Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2004.19.6.859","article-title":"An inverse relationship between ceramide synthesis and clinical severity in patients with psoriasis","volume":"19","author":"Cho","year":"2004","journal-title":"J Korean Med Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2007.22.5.862","article-title":"A study on altered expression of serine palmitoyltransferase and ceramidase in psoriatic skin lesion","volume":"22","author":"Hong","year":"2007","journal-title":"J Korean Med Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1046\/j.1523-1747.2001.01283.x","article-title":"The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris","volume":"116","author":"Alessandrini","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15185","article-title":"Lesional psoriasis is associated with alterations in the stratum corneum ceramide profile and concomitant decreases in barrier function","volume":"33","author":"Rousel","year":"2024","journal-title":"Exp Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2024.100591","article-title":"Guselkumab treatment normalizes the stratum corneum ceramide profile and alleviates barrier dysfunction in psoriasis: results of a randomized controlled trial","volume":"65","author":"Rousel","year":"2024","journal-title":"J Lipid Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00619-2","article-title":"Ceramides in skin health and disease: an update","volume":"22","author":"Uchida","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.199","article-title":"Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model","volume":"133","author":"Nakajima","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3390\/ijms26041673","article-title":"zDHHC-mediated S-palmitoylation in skin health and its targeting as a treatment perspective","volume":"26","author":"Abdulrahman","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.607442","article-title":"Zdhhc2 is essential for plasmacytoid dendritic cells mediated inflammatory response in psoriasis","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/biom16010053","article-title":"Protein S-palmitoylation as potential therapeutic target for dermatoses","volume":"16","author":"Feng","year":"2025","journal-title":"Biomolecules"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.AC119.011170","article-title":"A genome-wide CRISPR\/Cas9 screen reveals that the aryl hydrocarbon receptor stimulates sphingolipid levels","volume":"295","author":"Majumder","year":"2020","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.10.085","article-title":"Tapinarof in the treatment of psoriasis: a review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent","volume":"84","author":"Bissonnette","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans","volume":"137","author":"Smith","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1388690","article-title":"Discovery of biomarkers in the psoriasis through machine learning and dynamic immune infiltration in three types of skin lesions","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1374763","article-title":"Single-cell sequencing analysis and multiple machine-learning models revealed the cellular crosstalk of dendritic cells and identified FABP5 and KLRB1 as novel biomarkers for psoriasis","volume":"15","author":"Ma","year":"2024","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S492875","article-title":"Single-cell sequencing and machine learning integration to identify candidate biomarkers in psoriasis: INSIG1","volume":"17","author":"Zhou","year":"2024","journal-title":"J Inflammation Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-00553-7","article-title":"Structural insights into the assembly and substrate selectivity of human SPT-ORMDL3 complex","volume":"28","author":"Li","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg0728","article-title":"Mechanism of sphingolipid homeostasis revealed by structural analysis of Arabidopsis SPT-ORM1 complex","volume":"9","author":"Liu","year":"2023","journal-title":"Sci Adv"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac460","article-title":"SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegia","volume":"146","author":"Srivastava","year":"2023","journal-title":"Brain"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.03.018","article-title":"Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis","volume":"125","author":"Zaba","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-011-1125-0","article-title":"Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis","volume":"303","author":"Peternel","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jdermsci.2018.04.007","article-title":"RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis","volume":"91","author":"Saito","year":"2018","journal-title":"J Dermatol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112663","article-title":"Novel insights into immune checkpoints in psoriasis and atopic dermatitis: from expression and function to treatments","volume":"139","author":"Liu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"8259","DOI":"10.1038\/s41598-021-87795-7","article-title":"Ceramide kinase regulates TNF-alpha-induced immune responses in human monocytic cells","volume":"11","author":"Al-Rashed","year":"2021","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1856647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:20:14Z","timestamp":1784607614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1856647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2026.1856647"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1856647","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"article-number":"1856647"}}